Search

everythinglearnresearchcommunity

for

Search:↓

Oxidative stress affects hair loss in men with androgenetic alopecia.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Hair loss affects quality of life, self-esteem, and confidence, but younger patients cope better.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

Laser therapy and hair growth factors significantly improve hair density in male baldness.

Caffeine-based liquid 0.2% is as effective as minoxidil 5% for treating male hair loss.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Androgens can both increase body hair and cause scalp hair loss.

Smoking is linked to more hair loss and premature graying compared to nonsmokers.

Terbinafine can cause hair loss.

Both fat-derived stem cells and platelet-rich plasma are effective and safe for hair loss, but stem cells give better results with more side effects.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

Cyclosporin doesn't stop hair loss.

Early-onset male hair loss is linked to metabolic syndrome, suggesting a need for heart health monitoring and lifestyle changes.

Androgenetic alopecia is common in South-West Nigeria, affecting more men than women, with stress worsening the condition.

People with androgenetic alopecia have a higher risk of heart disease.

Severe hair loss in Chinese men is linked to high blood pressure, while in women, it's linked to larger waist size and cholesterol issues.

Activated platelet-rich plasma is a safe and effective treatment for hair loss.

Platelet-rich plasma injections significantly improved hair regrowth and thickness in patients with hair loss.

Higher testosterone and DHT levels are linked to hair loss in men, but not to prostate cancer risk.

Low-level laser therapy is the most supported treatment for hair loss, but other methods show promise.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

PRP injections improve hair density in male hair loss.

Finasteride effectively treats hair loss in transgender men with few side effects.

Lower zinc levels may predict less effective hair loss treatment.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.